Calviri
Peter P. Lee, M.D., is currently the chair of the Department of Immuno-Oncology at Beckman Research Institute of City of Hope and a beneficiary of The Christopher Family Endowed Innovation Fund for Alzheimer’s Disease and Breast Cancer Research in Honor of Vineta Christopher. He is co-leader of the Cancer Immunotherapeutics Program, professor in the Department of Hematology & Hematopoietic Cell Transplantation and the Billy and Audrey L. Wilder Professor in Cancer Immunotherapeutics. Dr. Lee received his medical degree at University of California San Diego and completed fellowships at both Stanford University and University of California San Francisco. The focus of his research is on understanding how cancer impacts host immune responses in patients, with the goal of developing novel treatments to restore/enhance immune function in cancer patients.
This person is not in the org chart
This person is not in any offices
Calviri
Calviri’s mission is to provide affordable products worldwide that will end deaths from cancer. They are a fully integrated healthcare company developing a broad spectrum of vaccines and companion diagnostics that prevent and treat cancer for those either at risk or diagnosed. They focus on using frameshift neoantigens derived from errors in RNA processing to provide pioneering products against cancer.